MaxCyte, Inc. (MXCT) vs Owlet, Inc. (OWLT)
- MaxCyte, Inc. MXCT 1.30 −0.76%
- Owlet, Inc. OWLT 4.15 −2.12%
MaxCyte, Inc. and Owlet, Inc. are both Medical Devices companies. MaxCyte, Inc. and Owlet, Inc. are of similar size ($135.2M and $123.9M). Owlet, Inc. grew revenue faster over the last twelve months: 28.0% against −13.2%. Owlet, Inc. has the higher net margin (−10.7% vs −114.8%) and the lower return on invested capital (−131.0% vs −49.2%). Across the 18 metrics below, Owlet, Inc. leads on 11 and MaxCyte, Inc. on 7.
Valuation
Profitability
| Metric | MXCT | OWLT | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.23% | 54.75% | 57.76% |
| Operating margin | (134.59%) | (6.67%) | (15.07%) |
| Net margin | (114.77%) | (10.67%) | (14.45%) |
| Free cash flow margin | (76.14%) | (8.59%) | (3.88%) |
| Return on equity | (20.39%) | 68.03% | (10.35%) |
| Return on assets | (17.62%) | (15.60%) | (17.26%) |
| Return on invested capital | (49.23%) | (131.04%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack